Table 1. Number of randomized, placebo-controlled statin trials that recorded LDL reduction, and percentage of LDL reduction achieved.

LDL reduction was calculated by subtracting the levels post-treatment with pre-treatment values in the statin cohort^{(88–93,95–97,99–102,104,106,107,109,110,113–117,119–122,124–128,130–132,135,136)}. In some studies, the placebo group also demonstrated LDL reduction. In these cases this value was subtracted from the reduction achieved in the treatment group.

Statin Trials	Number of studies	LDL reduction (%)
Pravastatin	14	24.3 ± 6.5
Simvastatin	6	32.6 ± 8.8
Atorvastatin	6	33.4 ± 8.9
Fluvastatin	4	25.5 ± 9.3
Lovastatin	3	30.6 ± 8.6
Rosuvastatin	1	41